Phylogica achieves research milestone

Australia |  News | By BioSpectrum Bureau  | 0 Comment | 05 Jun, 2012

Singapore: Phylogica, a public Australian peptide drug discovery company, has achieved a research milestone under its co...Read more

Alchemia appoints Kelley, Drona to its board

Australia |  News | By BioSpectrum Bureau  | 0 Comment | 22 Mar, 2013

Singapore: Australian drug discovery and development company Alchemia has appointed Dr Susan Kelley and Mr Nathan Drona ...Read more

Patrys' multiple myeloma clinical trial progresses

Australia |  News | By BioSpectrum Bureau  | 0 Comment | 12 Aug, 2013

Singapore: Patrys, a clinical stage biotechnology company, has received approval to progress its Phase I/IIa PAT-SM6 mul...Read more

Hatchtech takes on resistant head lice

Australia |  Analysis | By BioSpectrum Bureau  | 0 Comment | 05 Oct, 2012

Australia-based Hatchtech, which was started in October 2001, is developing a new generation of low-toxicity ovacides fo...Read more

"Like Indo-Australian relationship, nanobiotech has great potential"

Australia |  Opinion | By BioSpectrum Bureau  | 0 Comment | 03 Apr, 2014

Q: How do you look at the nano-biotech achievements in India so far? Have the applications been enough?Dr Pachauri: I th...Read more

Aus, Canada study find how diabetes drug metformin works

Australia |  News | By BioSpectrum Bureau  | 0 Comment | 25 Nov, 2013

Singapore: Researchers from St Vincent's Institute of Medical Research in Melbourne, Australia, in collaboration with re...Read more

UBI doubled its revenue to $29.6 mn in FY 2012

Australia |  News | By BioSpectrum Bureau  | 0 Comment | 14 Feb, 2013

Singapore: Universal Biosensors reported its unaudited financial result for FY 2012 including a doubling of total revenu...Read more

Pfizer trial of cancer drug INLYTA is a failure

Australia |  News | By BioSpectrum Bureau  | 0 Comment | 22 Oct, 2012

Singapore: Pfizer has revealed that its phase III study of INLYTA (axitinib) did not meet the primary endpoint of demons...Read more

ResMed builds on partnerships for growth

Australia |  Analysis | By BioSpectrum Bureau  | 0 Comment | 14 Jun, 2012

Driving in the niche industry of sleep disorders, ResMed was aggressive in strengthening its portfolio through acquisiti...Read more

Agenix seeks China SFDA nod for hepatitis candidate

Australia |  News | By BioSpectrum Bureau  | 0 Comment | 02 Apr, 2013

Singapore: Drug and diagnostic company Agenix announced that it was on track to submit a new drug clinical trial applic...Read more

Nanoparticles: A unique approach to cancer treatment

Australia |  News | By Nandita Singh | 0 Comment | 14 Mar, 2012

Nanoparticles as a drug delivery system enables unique approaches for cancer treatment. Over the last two decades, a lar...Read more

Prima cancer vaccine trial shows promise

Australia |  News | By BioSpectrum Bureau  | 0 Comment | 17 Oct, 2012

Singapore: Prima BioMed's interim data from the CAN-003 phase II clinical trial of cancer vaccine therapy, CVac, which ...Read more

Starpharma reports financial results for FY 2011-12

Australia |  Company results | By BioSpectrum Bureau  | 4 Comment | 03 Sep, 2012

Singapore: Starpharma reported net cash outflows from operating and investing activities for the year ending June 30, 20...Read more

GeneWorks develops DNA barcodes as security tool

Australia |  News | By BioSpectrum Bureau  | 0 Comment | 08 Aug, 2012

Singapore: South Australian biotechnology company, GeneWorks, developed a new DNA barcoding technology for use as a secu...Read more

BioPharma Asia: Bionomics wins Innovative Asian Biotech of the Year Award

Australia |  News | By BioSpectrum Bureau  | 0 Comment | 17 Mar, 2014

Singapore: Australia based Bionomics is recognized as the Innovative Asian Biotech of the Year at BioPharma Asia Industr...Read more

Mesoblast NeoFuse shows +ve results

Australia |  News | By BioSpectrum Bureau  | 0 Comment | 14 Jan, 2013

Singapore: Regenerative medicine company Mesoblast's phase II clinical trial for lumbar spinal fusion successfully met ...Read more

Australia approves drug for cystic fibrosis

Australia |  News | By BioSpectrum Bureau  | 0 Comment | 10 Jul, 2013

Singapore: US-based Vertex Pharmaceuticals has received Therapeutic Goods Administration (TGA) of Australia approval of ...Read more

Australian scientists discover new bowel cancer genes

Australia |  News | By BioSpectrum Bureau  | 0 Comment | 21 May, 2012

Singapore: A team of Australian scientists discovered new genes that show identifiable changes in the blood of people wi...Read more